Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of August 09, 2020
Computer model offers insights on COVID-19 super-spreading
New research compares transmission patterns of SARS-CoV-2 with those of influenza
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Validating antibody tests to determine SARS-CoV-2 seroprevalence
From the University of Washington and the Jerome lab, Vaccine and Infectious Disease Division
Q&A: Dr. Larry Corey at the center of COVID-19 vaccine research
Fred Hutch scientists will play key roles in 'harmonizing' clinical trials
Targeted single-cell RNA sequencing maximizes cellular information at a lower cost
From the Gottardo, Newell, and Prlic labs, Vaccine and Infectious Disease Division
Antiviral cytokines pick up T cell slack
From the Schiffer group, Vaccine and Infectious Disease Division
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Seattle area COVID-19 tests show infections declining
Trends in coronavirus test results suggest social distancing is working
Fine-tuning B cell responses
From the Taylor Lab, Vaccine and Infectious Disease Division
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Conference on gene therapy for HIV cures will highlight progress and challenges ahead
Dr. Robert Siliciano, keynote speaker, discovered why AIDS drugs alone cannot cure HIV
Two Irish microbiologists find their way, together, to Seattle
Microbiome experts Drs. Susan Bullman and Christopher Johnston join Fred Hutch
Infections in immune-compromised patients: 5 new frontiers
Infectious disease experts gather in Seattle to find solutions for patients with compromised immunity
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
5 questions on new dengue vaccine analysis
Asked to help re-examine clinical trial data, Fred Hutch biostatisticians foresee a new era of personalized vaccines
Stealing a secret from an unwelcome virus
An unexpected discovery in a herpes lab might bring relief to cancer patients
Renewed hope at AIDS conference for halting HIV through vaccine
At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
International AIDS Conference: Where we’ve been, what’s next in the quest to end HIV
The last time the International AIDS Conference was in Africa, AIDS denialism was at its height; two Fred Hutch leaders in the fight to end HIV talk about where we’ve been – and what’s next
Drug-filled vaginal ring protects women from HIV — when used correctly
Consistent use of ring protects against HIV infection by up to 92 percent, according to new analyses that measured the effectiveness of consistent vs. inconsistent use
Fred Hutch HIV cure program extended, expanded
DefeatHIV receives second five-year grant from NIH to research gene and cell therapies